A carregar...

A tale of two pities: Autologous melanoma vaccines on the brink

This paper reviews and compares two autologous vaccine technologies for human melanoma that failed to obtain marketing approval after 10–15 y of clinical development—the HSP vaccine invented by Srivastava and developed by the company, Antigenics, and the hapten-modified cellular vaccine invented by...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Autor principal: Berd, David
Formato: Artigo
Idioma:Inglês
Publicado em: Landes Bioscience 2012
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3551891/
https://ncbi.nlm.nih.gov/pubmed/22854662
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/hv.20923
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!